Yanqing Chen (Y Chen)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Patient Reported

Ejection Fraction

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Alexa B Kimball, Maurizio Podda, Afsaneh Alavi, Megan Miller, Yaung-Kaung Shen, Shu Li, Yan Xu, Chenglong Han, Steven Fakharzadeh, Ya-Wen Yang, Samuel DePrimo, Ernesto Munoz, Yanqing Chen, Thierry Passeron, Kim A Papp
Guselkumab for the Treatment of Patients with Moderate-to-severe Hidradenitis Suppurativa: A Phase 2 Randomized Study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Kim Campbell, Katherine Li, Feifei Yang, Patrick Branigan, M Merle Elloso, Jacqueline Benson, Yevgeniya Orlovsky, Yanqing Chen, Sandra Garcet, James G Krueger
Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab. ImmunoHorizons 7 (4) (2023)
Knut Schäkel, Kristian Reich, K Asadullah, Andreas Pinter, Denis Jullien, P Weisenseel, C Paul, M Gomez, S Wegner, Y Personke, F Kreimendahl, Yanqing Chen, J Angsana, M W L Leung, K Eyerich
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)